Listed by the USPTO as QIAN, CELINE X
Tech Center 1600 • Art Units: 1636 1637 1653 1656 1663 1699
This examiner grants 48% of resolved cases
QIAN, CELINE X works in Tech Center 1600 and Art Unit 1636, with 794 resolved cases. The allowance rate is 47.5%, the interview lift is 17.2%, and the median time to allowance is 1341 days. The figures indicate a docket where allowance is not routine and interviews provide a measurable, though limited, improvement association.
President and Fellows of Harvard College, The Regents of the University of California, and Board of Regents of the University of Texas System are the leading companies. Meunier Carlin & Curfman LLC, KAGAN BINDER, PLLC, and WC&F IP are the leading firms. Practitioners should prepare technically specific responses for complex institutional portfolios.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18555503 | INHIBITORY RNA FOR THE CONTROL OF PHYTOPATHOGENS | Non-Final OA | The Regents of the University of California |
| 18265662 | INNATE IMMUNE CELL SILENCING BY SIRP-ALPHA ENGAGER | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17778254 | SPLIT-ENZYME SYSTEM TO DETECT SPECIFIC DNA IN LIVING CELLS | Non-Final OA | The Regents of the University of California |
| 18735087 | MICRORNA-541-3P AS A THERAPEUTIC AGENT AS WELL AS ZNF101 AND CASZ1 AS THERAPEUTIC TARGETS TO LOWER PLASMA LDL-C, INCREASE PLASMA HDL-C, AND REDUCE ATHEROSCLEROSIS | Non-Final OA | The United States Government As Represented By The Department of Veterans Affairs |
| 18154575 | JAPANESE ENCEPHALITIS PREVENTIVE AGENT AND JAPANESE ENCEPHALITIS VACCINE AGENT | Non-Final OA | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy47.5% of resolved applications examined by Celine X Qian were allowed (794 resolved cases), compared with 37.1% across Art Unit 1636 over the last five years.
This examiner's interview lift is +17.2 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Celine X Qian took 1,341 days on average from filing to allowance.
Celine X Qian examines applications in Art Unit 1636 in Tech Center 1600 (Biotechnology & Pharmaceuticals).